These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

992 related items for PubMed ID: 19101233

  • 21. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure.
    Parissis JT, Nikolaou M, Farmakis D, Bistola V, Paraskevaidis IA, Adamopoulos S, Filippatos G, Kremastinos DT.
    Heart; 2008 May; 94(5):585-9. PubMed ID: 17761502
    [Abstract] [Full Text] [Related]

  • 22. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ, Zareba W, Bisognano JD.
    Am J Cardiol; 2007 Apr 15; 99(8):1143-5. PubMed ID: 17437744
    [Abstract] [Full Text] [Related]

  • 23. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
    Hogenhuis J, Voors AA, Jaarsma T, Hillege HL, Hoes AW, van Veldhuisen DJ.
    Am Heart J; 2006 May 15; 151(5):1012.e1-5. PubMed ID: 16644323
    [Abstract] [Full Text] [Related]

  • 24. Independent value of echocardiography and N-terminal pro-natriuretic Peptide for the prediction of major outcomes in patients with suspected heart failure.
    Lim TK, Hayat SA, Gaze D, Celik E, Collinson P, Senior R.
    Am J Cardiol; 2007 Sep 01; 100(5):870-5. PubMed ID: 17719336
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F, Liska J, Franco-Cereceda A.
    Interact Cardiovasc Thorac Surg; 2009 Feb 01; 8(2):191-4. PubMed ID: 19008326
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, Cambien F, Tiret L, Münzel T, Blankenberg S.
    J Am Coll Cardiol; 2006 Feb 07; 47(3):552-8. PubMed ID: 16458135
    [Abstract] [Full Text] [Related]

  • 30. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
    Gwechenberger M, Pacher R, Berger R, Zorn G, Moser P, Stanek B, Huelsmann M.
    J Heart Lung Transplant; 2005 Dec 07; 24(12):2190-5. PubMed ID: 16364870
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
    Passino C, Pingitore A, Landi P, Fontana M, Zyw L, Clerico A, Emdin M, Iervasi G.
    J Card Fail; 2009 Feb 07; 15(1):35-40. PubMed ID: 19181292
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Bistola V, Parissis JT, Paraskevaidis I, Panou F, Nikolaou M, Ikonomidis I, Flessas N, Filippatos G, Iliodromitis E, Kremastinos DT.
    Am J Cardiol; 2010 Jan 15; 105(2):249-54. PubMed ID: 20102927
    [Abstract] [Full Text] [Related]

  • 35. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
    Zhao XY, Yang YJ, Zhang J, Dang AM, Ni XH, Huang J, Kang S, Ma WH, Zhao DY.
    Zhonghua Yi Xue Za Zhi; 2006 May 09; 86(17):1165-9. PubMed ID: 16796855
    [Abstract] [Full Text] [Related]

  • 36. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GY.
    Am J Cardiol; 2006 Mar 01; 97(5):671-5. PubMed ID: 16490435
    [Abstract] [Full Text] [Related]

  • 37. Does clinician's knowledge of B-type natriuretic peptide levels translate to improvement of quality of life and less hospitalization days in patients with heart failure?
    Ancheta IB, Evans M, Miller AB, Chiong JR, Battie C.
    Prog Cardiovasc Nurs; 2009 Mar 01; 24(1):12-8. PubMed ID: 19261138
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Health status identifies heart failure outpatients at risk for hospitalization or death.
    Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS, Peterson ED, Masoudi FA, Krumholz HM, Havranek EP, Conard MW, Williams RE, Cardiovascular Outcomes Research Consortium.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):752-6. PubMed ID: 16487840
    [Abstract] [Full Text] [Related]

  • 40. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.
    Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, Yoshihara F, Nakamura S, Nakahama H, Inenaga T, Kangawa K, Kawano Y.
    Am J Kidney Dis; 2004 Sep 21; 44(3):420-8. PubMed ID: 15332214
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.